New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareGlutathione vs Adipotide

Glutathione vs Adipotide

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & LongevityImmune Support
Glutathione
Fat Loss & Metabolic
Adipotide
Summary
Glutathione is the body's master endogenous antioxidant tripeptide, composed of glutamate, cysteine, and glycine. It neutralizes reactive oxygen species, supports detoxification in the liver, recycles other antioxidants (vitamins C and E), and plays a central role in immune function, DNA repair, and cellular redox balance.
Adipotide (FTPP) is a chimeric proapoptotic peptide that selectively targets and destroys blood vessels feeding white adipose tissue. It binds prohibitin on the vasculature of fat tissue, delivering a proapoptotic sequence that induces cell death in fat-specific blood vessels, causing targeted fat tissue regression.
Half-Life
Minutes to hours depending on route; IV half-life approximately 10-30 minutes
Estimated 2-4 hours
Admin Route
Oral (liposomal preferred), Sublingual, Intravenous, Nebulized/inhaled, Topical
Subcutaneous, Intravenous (research)
Research
Typical Dose
250-1000 mg per day
Not established for humans; primate studies used 0.1-1 mg/kg
Frequency
Once or twice daily
Daily for 4 weeks (research protocol)
Key Benefits
  • Primary endogenous antioxidant and free radical scavenger
  • Supports hepatic detoxification of xenobiotics and heavy metals
  • Recycles vitamins C and E to maintain antioxidant network
  • Modulates immune function and T-cell activity
  • Skin brightening via inhibition of tyrosinase (IV/topical routes)
  • Neuroprotective in oxidative stress-related conditions
  • Mitochondrial protection and energy metabolism support
  • Targeted reduction of white adipose tissue
  • Promotes fat vasculature apoptosis without systemic toxicity
  • Demonstrated significant fat loss in primate studies
  • Potential for visceral and subcutaneous fat reduction
  • Novel non-hormonal mechanism distinct from GLP-1 agonists
  • Explored for obesity and metabolic syndrome
Side Effects
  • Oral bioavailability is limited (largely hydrolyzed in gut); liposomal or sublingual forms preferred
  • IV administration: rare allergic reactions, vein irritation
  • High-dose supplementation may cause zinc depletion over time
  • Inhaled glutathione may trigger bronchoconstriction in asthmatics
  • Renal toxicity observed in primate studies (transient, dose-dependent)
  • Dehydration and electrolyte imbalances in research
  • Weight regain upon cessation
  • Limited human data; side effect profile largely from animal studies
Stacks With